Impact of clinical target volume margin reduction in glioblastoma patients treated with concurrent chemoradiation.

Autor: Di Perri D; Department of Radiation Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Hofstede D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Hartgerink D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Terhaag K; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Houben R; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Postma AA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, MHeNs School for Mental Health and Neuroscience, Maastricht, The Netherlands., Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Anten M; Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Ackermans L; Department of Neurosurgery, Maastricht University Medical Centre+, Maastricht, The Netherlands., Compter I; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Eekers DBP; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Publikováno v: Neuro-oncology practice [Neurooncol Pract] 2023 Oct 27; Vol. 11 (3), pp. 249-254. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2024).

PO-1959 Dosimetric benefits of proton therapy over (non)-coplanar photon radiotherapy in pituitary adenoma

Autor: Nogarede, M., Swinnen, A., Decabooter, E., Emmah, R., Verheesen, L., Beurskens, H., Hartgerink, D., in 't Ven, L., Houben, R., Roelofs, E., Eekers, D.B., Compter, I.

Publikováno v: In Radiotherapy and Oncology May 2023 182 Supplement 1:S1721-S1722

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.

Autor: Hartgerink D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Bruynzeel A; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., Eekers D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Swinnen A; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Hurkmans C; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Wiggenraad R; Department of Radiation Oncology, Haaglanden Medical Center, the Netherlands., Swaak-Kragten A; Department of Radiation Oncology, Erasmus MC, Rotterdam, the Netherlands., Dieleman E; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Oei B; Department of Radiation Oncology, Verbeeten Institute Tilburg, the Netherlands., van Veelen L; Department of Radiation Oncology, Zuid-West Radiotherapy Institute Vlissingen, the Netherlands., Verhoeff J; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Lagerwaard F; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Lambin P; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands., Zindler J; Department of Radiation Oncology, Haaglanden MC, Den Haag, the Netherlands.; Holland Proton Therapy Center, Delft, the Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2021 Feb 01; Vol. 3 (1), pp. vdab021. Date of Electronic Publication: 2021 Feb 01 (Print Publication: 2021).

LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation.

Autor: Hartgerink D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center , Maastricht , The Netherlands., Swinnen A; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center , Maastricht , The Netherlands., Roberge D; Department of Radiation Oncology, CHUM , Montreal , QC , Canada., Nichol A; Department of Radiation Oncology, CHUM , Montreal , QC , Canada., Zygmanski P; Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School , Boston , Massachusetts , USA., Yin FF; Department of Radiation Oncology, Duke University Medical Center , Durham , North Carolina , USA., Deblois F; Department of Radiation Oncology, CHUM , Montreal , QC , Canada., Hurkmans C; Department of Radiation Oncology, Catharina Hospital , Eindhoven , The Netherlands., Ong CL; Department of Radiation Oncology, HagaZiekenhuis , Den Haag , The Netherlands., Bruynzeel A; Department of Radiotherapy, Cancer Center Amsterdam, VU University medical center , Amsterdam , The Netherlands., Aizer A; Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School , Boston , Massachusetts , USA., Fiveash J; Department of Radiation Oncology, University of Alabama at Birmingham , Birmingham , Alabama , USA., Kirckpatrick J; Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School , Boston , Massachusetts , USA., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich , Zürich , Switzerland., Andratschke N; Department of Radiation Oncology, University Hospital Zürich , Zürich , Switzerland., de Ruysscher D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center , Maastricht , The Netherlands., Popple R; Department of Radiation Oncology, University of Alabama at Birmingham , Birmingham , Alabama , USA., Zindler J; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center , Maastricht , The Netherlands.; Department of Radiation Oncology, Erasmus MC , Rotterdam , The Netherlands.; Holland Proton Therapy Center , Delft , The Netherlands.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Sep; Vol. 58 (9), pp. 1275-1282. Date of Electronic Publication: 2019 Jul 01.